{
    "Trade/Device Name(s)": [
        "Pregnancy-SkreenTM",
        "hCG Liquid Control Urine \u2013 Negative",
        "hCG Liquid Control Urine - Positive"
    ],
    "Submitter Information": "Biochemical Diagnostics, Inc.",
    "510(k) Number": "K050328",
    "Predicate Device Reference 510(k) Number(s)": [
        "K965171",
        "K031231",
        "K042446",
        "K971886",
        "K972748",
        "K020799",
        "K925586"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "March 29, 2005",
    "Summary Letter Received Date": "February 9, 2005",
    "Submission Date": "February 8, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Human Chorionic Gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunoassay",
        "Immunochromatographic device"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Biochemical Diagnostics Pregnancy-SkreenTM hCG urine controls used to validate qualitative hCG immunoassay procedures.",
    "Indications for Use Summary": "Intended for health care professionals to validate qualitative hCG urine methods by treating controls as unknown specimens according to assay protocol.",
    "fda_folder": "Clinical Chemistry"
}